Senate Confirms Erica Schwartz as CDC Director After Yearlong Vacancy

Today, the US Senate confirmed Erica Schwartz, MD, JD, MPH, to lead the CDC, making her the agency's first Senate-confirmed permanent director in nearly a year.¹ Schwartz succeeds Jay Bhattacharya, MD, PhD, who had been overseeing the agency while also serving as director of the National Institutes of Health.

The CDC has lacked permanent leadership since August 2025, when HHS Secretary Robert F. Kennedy Jr removed Susan Monarez, PhD, just 29 days after she became CDC director. Monarez's departure followed a dispute over whether vaccine guidance from the agency's advisory panel should be approved without additional independent review.

Before her nomination, Schwartz served as deputy surgeon general during the first Trump administration and previously worked as a Navy physician and chief medical officer of the US Coast Guard. The administration nominated Schwartz after questions arose about the length of the CDC's period of interim leadership following the expiration of the acting director timeline under the Federal Vacancies Reform Act.

Questions Raised in a Contentious Hearing

Compared with several recent health nominees, Schwartz was generally viewed by many public health observers as a more conventional choice for the CDC role. However, some public health experts said she did not go far enough during her Senate hearing to distance herself from several controversial positions advanced by Kennedy and the HHS.

Schwartz affirmed that vaccines are safe and effective but said she was unaware of some Kennedy-led policy changes and declined to comment on whether she supported specific actions.

Senate Health, Education, Labor, and Pensions (HELP) Committee Chairman Bill Cassidy, MD (R, Louisiana), pressed Schwartz on whether she would challenge Kennedy if he attempted to undermine established science. Cassidy initially suggested that Schwartz had avoided directly answering the question but later expressed confidence in her independence after additional conversations with Schwartz and colleagues familiar with her work.

The committee advanced Schwartz's nomination on July 30 in a 13-10 vote.²

Cassidy also cited a recent HHS revision of a CDC webpage discussing vaccines and autism as a sign of good faith.¹ The updated page states that studies have not ruled out a link between childhood vaccines and autism, a position that conflicts with decades of research and longstanding scientific consensus finding no causal association between vaccines and autism. The revised page also notes that the root causes of autism have not been identified.

Not all public health observers were reassured. The National Public Health Coalition, a group of former CDC employees critical of Kennedy's leadership, said Schwartz's commitments during the hearing were too often incomplete or vague to earn its support. Additionally, an HHS spokesperson argued that criticizing Schwartz for not speculating on policy questions outside the scope of her nomination amounted to political theater.

For her part, Schwartz told the committee, "I will never betray the science."

Outbreaks and Vaccine Hesitancy Await the New Director

Schwartz inherits a CDC responding to a measles outbreak that has produced the highest US case count in 35 years, along with an ongoing cyclosporiasis outbreak linked to shredded iceberg lettuce. She also takes over amid continued debate over federal vaccine policy, including changes to vaccine advisory structures and efforts by the Kennedy-led HHS to revise federal immunization recommendations. Experts have warned that policy changes and public messaging from federal health officials could further affect vaccine confidence and uptake.

Key Takeways for Managed Care

A permanent CDC director restores a formal point of accountability for vaccine recommendations and outbreak response, areas that managed care organizations rely on for benefit design, quality measurement, and public health coordination. However, Schwartz begins her tenure amid active outbreaks, ongoing legal and policy disputes involving federal immunization recommendations, and changes to the CDC's vaccine advisory framework.

Payers and health systems will likely continue monitoring changes in federal vaccine recommendations and outbreak guidance as Schwartz begins her tenure and works to define the agency's scientific and operational direction.

References

1. Bendix A. New CDC director is confirmed, giving agency its first permanent leader in a year. NBC News. August 5, 2026. Accessed August 5, 2026. https://www.nbcnews.com/health/health-news/new-cdc-director-confirmed-erica-shwartz-rcna590994
2. Cirruzzo C. Senate panel backs CDC director, pandemic preparedness nominees. STAT News. July 30, 2026. Accessed August 5, 2026. https://www.statnews.com/2026/07/30/senate-panel-backs-confirmation-health-nominees-schwartz-cdc-kaufman-aspr/